New strategy for oral cancer based on molecular imaging reflecting therapeutic resistance
Project/Area Number |
16H05536
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Surgical dentistry
|
Research Institution | Hokkaido University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
竹内 康人 北海道大学, 遺伝子病制御研究所, 特別研究員(PD) (10735187)
大賀 則孝 北海道大学, 歯学研究院, 助教 (40548202)
佐藤 淳 北海道大学, 歯学研究院, 講師 (60319069)
久下 裕司 北海道大学, アイソトープ総合センター, 教授 (70321958)
犬伏 正幸 川崎医科大学, 医学部, 准教授 (70399830)
玉木 長良 北海道大学, 医学研究科, 特任教授 (30171888)
|
Project Period (FY) |
2016-04-01 – 2019-03-31
|
Project Status |
Completed (Fiscal Year 2018)
|
Budget Amount *help |
¥17,290,000 (Direct Cost: ¥13,300,000、Indirect Cost: ¥3,990,000)
Fiscal Year 2018: ¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2016: ¥7,670,000 (Direct Cost: ¥5,900,000、Indirect Cost: ¥1,770,000)
|
Keywords | 分子イメージング / 遺伝子イメージング / 低酸素 / 遺伝子応答 / PET / 治療抵抗性 / 化学療法 / 頭頸部癌 / FMISO / 口腔がん / 臨床研究 / 動物モデル / 核医学(PET) / 核医学 (PET) / FIMISO / 核医学(PET) / 核医学(PET) |
Outline of Final Research Achievements |
Hypoxia is a negative prognostic factor due to its association with an aggressiveness and therapeutic resistance. HIF-1/HRE pathway is a promising target for the imaging and the treatment of intractable malignancy (HIF-1; hypoxia-inducible factor 1, HRE; hypoxia responsive element). The tumor uptake level of hypoxia-targeted PET tracers reflected the gene activation level of HRE, which eventually conferred resistance to anti-cancer therapies. FMISO-PET and FDG-PET were performed in patients with oral SCC (OSCC) to elucidate the correlation between PET uptake and various parameters. FMISO uptake was an independent significant predictor of response to preoperative chemotherapy. hypoxic volume (HV) correlated significantly with both disease-free survival and loco-regional recurrence. Tumor HV measured by FMISO-PET may predict outcomes in patients with OSCC.
|
Academic Significance and Societal Importance of the Research Achievements |
腫瘍内環境における低酸素は多くの固形癌の強力な予後因子とされているが、低酸素状態の可視化は極めて困難であった。われわれは低酸素状態で遺伝子応答する癌細胞株を樹立し、動物実験でイメージングに成功した。さらに低酸素分子イメージングとしてFMISO-PETを口腔癌に臨床応用した。FMISO-PETの集積と組織中のHIF-1αの発現が有意に関連していることを世界で初めて明らかにした。術前化学療法の効果の予測、増殖能との関係、低酸素容積と予後との関連も見いだした。
|
Report
(4 results)
Research Products
(27 results)
-
[Journal Article] Imaging modalities for drug-related osteonecrosis of the jaw (3), Positron emission tomography imaging for the diagnosis of medication-related osteonecrosis of the jaw.2019
Author(s)
Kitagawa Y, Ohga N, Asaka T, Sato J, Hata H, Helman J, Tsuboi K, Amizuka N, Kuge Y, Shiga T
-
Journal Title
Jpn Dent Sci Rev
Volume: 55
Issue: 1
Pages: 65-70
DOI
NAID
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
-
-
[Journal Article] 18F-Fluoromisonidazole positron emission tomography (FMISO-PET) may reflect hypoxia and cell proliferation activity in oral squamous cell carcinoma.2017
Author(s)
Sato J, Kitagawa Y, Watanabe S, Asaka T, Ohga N, Hirata K, Okamoto S, Shiga T, Shindoh M, Kuge Y, Tamaki N.
-
Journal Title
Oral Surg Oral Med Oral Pathol Oral Radiol
Volume: 124(3)
Issue: 3
Pages: 261-270
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Dynamic PET evaluation of elevated FLT level after sorafenib treatment in mice bearing human renal cell carcinoma xenograft.2016
Author(s)
Ukon N, Zhao S, Yu W, Shimizu Y, Nishijima KI, Kubo N, Kitagawa Y, Tamaki N, Higashikawa K, Yasui H, Kuge Y
-
Journal Title
EJNMMI Res
Volume: 6(1)
Issue: 1
Pages: 90-90
DOI
NAID
Related Report
Peer Reviewed
-
-
-
-
-
[Journal Article] The reoxygenation of hypoxia and the reduction of glucose metabolism in head and neck cancer by fractionated radiotherapy with intensity-modulated radiation therapy.2016
Author(s)
Okamoto S, Shiga T, Yasuda K, Watanabe S, Hirata K, Nishijima KI, Magota K, Kasai K, Onimaru R, Tuchiya K, Kuge Y, Shirato H, Tamaki N.
-
Journal Title
Eur J Nucl Med Mol Imaging
Volume: 43(12)
Issue: 12
Pages: 2147-2154
DOI
Related Report
Peer Reviewed
-
-
-
-
-
[Presentation] Prognostic value of MET-PET in oral cancer2017
Author(s)
Chowdhury Nusrat Fatema, Kuroshima Takeshi, Asaka Takuya, Abe Takahiro, Sato Jun, Shiga Tohru, Kuge Yuji, Tamaki Nagara, Kitagawa, Yoshimasa
Organizer
The 64th Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging
Related Report
Int'l Joint Research
-
[Presentation] 18F-Fluoromisonidazole positron emission tomography (FMISO-PET) may better reflect hypoxia and cell proliferation activity in oral squamous cell carcinoma than 18F-fluoro-2-deoxyglucose (FDG)-PET: third study.2017
Author(s)
Sato Jun, Kitagawa Yoshimasa, Watanabe Shiro, Okamoto Shozo, Ohga, Noritaka, Asaka Takuya, Miyakoshi Masaaki, Hirata Kenji, Shiga Tohru, Kuge Yuji, Shindoh Masanobu, Tamaki Nagara
Organizer
The 64th Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging
Related Report
Int'l Joint Research
-
-
-
-
-
-
[Presentation] Usefulness of MET-PET in oral cancer2016
Author(s)
Chowdhury Nusrat Fatema, Takeshi Kuroshima, Takuya Asaka, Takahiro Abe, Jun Sato, Yoshimasa Kitagawa
Organizer
61st Congress of the Japanese Society of Oral and Maxillofacial Surgeons
Place of Presentation
幕張メッセ(千葉県・千葉市)
Year and Date
2016-11-25
Related Report
-
[Presentation] Relationships between FMISO- and FDG-PET parameters including hypoxic volume of the tumor and prognosis in patients with oral squamous cell carcinoma after surgery2016
Author(s)
Sato, Jun, Kitagawa, Yoshimasa, Watanabe, Shiro, Kenji Hirata, Okamoto, Shozo, Noritaka, Ohga, Asaka, Takuya, Miyakoshi, Masaaki, Hata, Hironobu, Shiga Tohru, Shindoh Masanobu, Tamaki Nagara
Organizer
Annual Congress of the European Association of Nuclear Medicine
Place of Presentation
Barcelona (Spain)
Year and Date
2016-10-18
Related Report
Int'l Joint Research
-